References
- Sunderam S, Kissin DM, Crawford SB, et al. Centers for Disease Control and Prevention (CDC). Assisted reproductive technology surveillance–United States, 2011. MMWR Surveill Summ 2014;63:1–28
- Fauser BC, Mannaerts BM, Devroey P, et al. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle stimulating activity and reduced injection frequency. Hum Reprod Update 2009;15:309–21
- Croxtall JD, McKeage K. Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction. BioDrugs 2011;25:243–54
- Fares FA, Suganuma N, Nishimori K, et al. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc Natl Acad Sci USA 1992;89:4304–8
- Devroey P, Boostanfar R, Koper NP, et al. A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod 2009;24:3063–72
- Corifollitropin alfa Ensure Study Group. Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women. Reprod Biomed Online 2010;21:66–76
- Boostanfar R, Shapiro B, Levy M, et al. Large, comparative, randomized double-blind trial confirming non-inferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol in older patients undergoing in vitro fertilization. Fertil Steril 2015;104:94–103.e1
- Griesinger G, Boostanfar R, Gordon K, et al. Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis. Reprod Biomed Online 2016;33:56–60
- Fensore S, Di Marzio M, Tiboni GM. Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysis. J Ovarian Res 2015;8:33
- Pouwer AW, Farquhar C, Kremer JA. Long-acting FSH versus daily FSH for women undergoing assisted reproduction. Cochrane Database Syst Rev 2015;7:CD009577
- Oehninger S, Nelson SM, Verweij P, et al. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles. Reprod Biol Endocrinol 2015;13:117
- Polyzos NP, Tournaye H, Guzman L, et al. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2013;100:430–7
- Ferraretti AP, La Marca A, Fauser BC, ESHRE working group on Poor Ovarian Response Definition, et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–24
- Siristatidis C, Askoxylaki M, Varounis C, et al. E-selectin, resistin and reactive oxygen species levels in GnRH -agonist and -antagonist protocols in IVF/ICSI: a prospective cohort study. J Assist Reprod Genet 2015;32:959–67
- Ziebe S, Petersen K, Lindenberg S, et al. Embryo morphology or cleavage stage: how to select the best embryos for transfer after in-vitro fertilization. Hum Reprod 1997;12:1545–9
- Abyholm T, Anderson AN, Balen AH, et al. A randomized dose- response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. Hum Reprod 2008;23:2484–92
- Sioulas V, Siristatidis C, Chrelias C, et al. Corifollitropin alfa vs. recombinant follicle stimulating hormone in ovarian stimulation of wo undergoing in vitro fertilization: preliminary results. Fertil Steril 2011;96:S181 P–252
- Devroey P, Fauser BC, Platteau P, et al. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metabol 2004;89:2062–20
- Mahmoud Youssef MA, van Wely M, Aboulfoutouh I, et al. Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis. Fertil Steril 2012;97:876–85
- Ledger WL, Fauser BC, Devroey P, et al. Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. Reprod Biomed Online 2011;23:150–9